BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1309264)

  • 21. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
    Staffa A; Cochrane A
    J Virol; 1994 May; 68(5):3071-9. PubMed ID: 7512159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of spliced and unspliced Rous sarcoma virus RNAs early and late after infection of chicken embryo fibroblasts: effect of cell culture conditions.
    Berberich SL; Stoltzfus CM
    Virology; 1991 May; 182(1):135-44. PubMed ID: 1850899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus.
    Fogel BL; McNally MT
    J Biol Chem; 2000 Oct; 275(41):32371-8. PubMed ID: 10934202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing.
    Gontarek RR; McNally MT; Beemon K
    Genes Dev; 1993 Oct; 7(10):1926-36. PubMed ID: 8405999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and nucleotide sequences of cDNAs spanning the splice junctions of Rous sarcoma virus mRNAs.
    Chang LJ; Stoltzfus CM
    J Virol; 1985 Mar; 53(3):969-72. PubMed ID: 2579248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transduction of c-src coding and intron sequences by a transformation-defective deletion mutant of Rous sarcoma virus.
    Soong MM; Iijima S; Wang LH
    J Virol; 1986 Sep; 59(3):556-63. PubMed ID: 3016320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between the negative regulator of splicing element and a 3' splice site: requirement for U1 small nuclear ribonucleoprotein and the 3' splice site branch point/pyrimidine tract.
    Cook CR; McNally MT
    J Virol; 1999 Mar; 73(3):2394-400. PubMed ID: 9971823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
    Si Z; Amendt BA; Stoltzfus CM
    Nucleic Acids Res; 1997 Feb; 25(4):861-7. PubMed ID: 9016638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA.
    Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1985 Sep; 5(9):2341-8. PubMed ID: 2426579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.
    Banks JD; Kealoha BO; Linial ML
    J Virol; 1999 Nov; 73(11):8926-33. PubMed ID: 10515997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
    Maciolek NL; McNally MT
    J Virol; 2007 Oct; 81(20):11208-17. PubMed ID: 17670832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA.
    Fu XD; Katz RA; Skalka AM; Maniatis T
    Genes Dev; 1991 Feb; 5(2):211-20. PubMed ID: 1847346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides.
    Hackett PB; Swanstrom R; Varmus HE; Bishop JM
    J Virol; 1982 Feb; 41(2):527-34. PubMed ID: 6281464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rous sarcoma virus negative regulator of splicing selectively suppresses SRC mRNA splicing and promotes polyadenylation.
    O'Sullivan CT; Polony TS; Paca RE; Beemon KL
    Virology; 2002 Oct; 302(2):405-12. PubMed ID: 12441084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the rous sarcoma virus DR posttranscriptional control element.
    Ogert RA; Beemon KL
    J Virol; 1998 Apr; 72(4):3407-11. PubMed ID: 9525671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.
    Hibbert CS; Gontarek RR; Beemon KL
    RNA; 1999 Mar; 5(3):333-43. PubMed ID: 10094303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of retroviral RNA splicing through maintenance of suboptimal processing signals.
    Katz RA; Skalka AM
    Mol Cell Biol; 1990 Feb; 10(2):696-704. PubMed ID: 2153921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence.
    Paca RE; Hibbert CS; O'Sullivan CT; Beemon KL
    J Virol; 2001 Aug; 75(16):7763-8. PubMed ID: 11462052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.